The trend of a healthy lifestyle enjoys a sustainably growing attraction across all age groups.
Railcare presterar bra i väntan på nya uppdrag och trots kursuppgången de tre senaste månaderna finn...
LIMES signed a preliminary yet binding agreement to acquire the operating company of the “Villa Bocc...
Bittium announced another order from the Finnish Defence Forces, worth of EUR 7m in total to be deli...
On 18 November 2025, Mendus entered into a loan facility with Fenja (of SEK 50m in total).
Cereno Scientific has strengthened CS1’s commercial positioning with a third Canadian patent, extend...
Director of M&A and Business Development, Sebastian Seppänen, has been appointed as interim CFO of R...
Redeye provides an initial comment on BioVica’s Q4 2025/2026 report.
GFT’s quality banking IT franchise, AI-enabled project expansion and UK/smartshore margin levers rem...
Aiforia agrees non-binding EIB term sheet for up to €20m venture debt, materially de-risking the fun...
The list of qualified suppliers for the large UK tactical communication tender was published today.
We foresee strong PFPM/share growth in Q2, up 27% y/y (c.
Redeye comments on Faron's updated BEXMAB data presented at EHA 2026, which demonstrated continued m...
* Q2e: 13% organic sales growth, 4.5% EBITA margin * We raise opex on increased competition * Tradin...
Bittium announced a strengthening to its AI-based offering, building on its other recent announcemen...
We update our base case after having analysed the ADVANCE data.
Redeye views the topline data as confirming a bell-shaped dose-response with resomelagon.
* Infrea and Netel to merger * The combined company to have ~SEK 5bn in revenue * Stynnergies of ~SE...
Freemelt’s investor update on June 2nd shed some light on the progress within the business verticals...
Xbrane has partnered with California-based CDMO JOINN Biologics to advance CMC development of Xdarza...
